Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway
B.-Q. Wu, Y. Cao, Z.-G. Bi Department of Orthopedics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway, by B.-Q. Wu, Y. Cao, Z.-G. Bi, published in Eur Rev Med Pharmacol Sci 2017; 21 (14): 3185-3192–PMID: 28770967” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadSuppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
B.-Q. Wu, Y. Cao, Z.-G. Bi
Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7548-7548
DOI: 10.26355/eurrev_202007_22189